| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |